Peptide chirality and opioid receptor modulation: Hepatoprotective effect of d-Met-enkephalin in acetaminophen-induced liver injury
Acta Pharmaceutica · 2025
DOI: 10.2478/acph-2025-0036 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica, 2025. Verfasst von Petra Turčić und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmacology 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Acetaminophen, Enkephalin, Methionine, Receptors, Opioid. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
l -Met-enkephalin is a neuropeptide known to exert protective effects in various experimental models of autoimmune and inflammatory diseases. These effects are mediated through opioid receptors and can be abolished by the opioid receptor antagonist naltrexone. Investigation of peptide enantiomerism and the incorporation of d-amino acids are crucial for designing novel peptides with altered structural and biological properties compared with their native l-forms. Since no data are currently available on the properties or biological activity of the d-Met-enkephalin enantiomer, we evaluated its hepatoprotective potential in a mouse model of acetaminophen-induced hepatotoxicity. Male CBA mice were treated with d-Met-enkephalin, and hepatoprotection was assessed by measuring plasma alanine aminotransferase (ALT) and aspartate amino-transferase (AST) activities, along with histological liver necrosis scores. The peptide’s secondary structure and antisense peptide binding were analysed using circular dichroism and fluorescence spectroscopy, respectively. d -Met-enkephalin demonstrated dose-dependent hepatoprotective effects within the range of 0.5–20 mg kg–1, with maximal protection observed at 5 mg kg –1 , a dose comparable to that of the l-enantiomer (7.5 mg kg –1 ). This preservation of biological activity may be attributed to the presence of the achiral amino acid glycine at positions 2 and 3, which maintains the functional conformation of the d-enantiomer. The role of opioid receptor involvement was further examined through direct receptor blockade using naltrexone and indirect inhibition with the antisense peptide IPPKY.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Pharmacology 10000 Zagreb, Croatia.
- General and Veterans Hospital Knin 22300 Knin, Croatia.
- Ruđer Bošković Institute, Center for Nuclear Magnetic Resonance, 10000 Zagreb, Croatia.
- University of Zagreb Faculty of Pharmacy and Biochemistry, Department of General and Inorganic Chemistry, 10000 Zagreb, Croatia.
- University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
- University of Zagreb School of Medicine Department of Pharmacology, 10000 Zagreb Croatia.
ORCID-Profile: Petra Turčić, Nikola Štambuk, Tin Weitner, Mirna Momčilović, Alenka Boban-Blagaić, Ranko Stojković
Zitieren
APA
Turčić, P., Martinić, R., Štambuk, N., Weitner, T., Momčilović, M., Boban-Blagaić, A., Kos, M., & Stojković, R. (2025). Peptide chirality and opioid receptor modulation: Hepatoprotective effect of d-Met-enkephalin in acetaminophen-induced liver injury. Acta Pharmaceutica. https://doi.org/10.2478/acph-2025-0036
Vancouver
Turčić P, Martinić R, Štambuk N, Weitner T, Momčilović M, Boban-Blagaić A, et al. Peptide chirality and opioid receptor modulation: Hepatoprotective effect of d-Met-enkephalin in acetaminophen-induced liver injury. Acta Pharmaceutica. 2025. doi:10.2478/acph-2025-0036
BibTeX
@article{Turi2025,
author = {Turčić, Petra and Martinić, Roko and Štambuk, Nikola and Weitner, Tin and Momčilović, Mirna and Boban-Blagaić, Alenka and Kos, Marina and Stojković, Ranko},
title = {Peptide chirality and opioid receptor modulation: Hepatoprotective effect of d-Met-enkephalin in acetaminophen-induced liver injury},
journal = {Acta Pharmaceutica},
year = {2025},
doi = {10.2478/acph-2025-0036}
}
EUVIMED